Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
3.700
+0.020 (0.54%)
Dec 5, 2025, 4:00 PM EST - Market closed
Larimar Therapeutics Employees
Larimar Therapeutics had 65 employees as of December 31, 2024. The number of employees increased by 23 or 54.76% compared to the previous year.
Employees
65
Change (1Y)
23
Growth (1Y)
54.76%
Revenue / Employee
n/a
Profits / Employee
-$2,030,754
Market Cap
316.68M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
LRMR News
- 3 days ago - Top 3 Health Care Stocks That May Rocket Higher In December - Benzinga
- 4 weeks ago - Larimar Therapeutics Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 7 weeks ago - Larimar Therapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - LRMR - PRNewsWire
- 7 weeks ago - LRMR Investors Have Opportunity to Join Larimar Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - PRNewsWire
- 7 weeks ago - Larimar Therapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – LRMR - Business Wire
- 2 months ago - Larimar Therapeutics, Inc. - Special Call - Seeking Alpha
- 2 months ago - Larimar Therapeutics Stock Falls After Patients Report Allergic Reaction In Pivotal Study - Benzinga
- 2 months ago - Larimar Therapeutics Announces Positive Data from Ongoing Long-term Open Label Study and Updates to Nomlabofusp Program for Friedreich's Ataxia - GlobeNewsWire